Ladenburg Thalmann Financial Services’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-116
| Closed | – | – | 5702 |
|
|
2019
Q3 | $0 | Hold |
116
| – | – | ﹤0.01% | 5616 |
|
|
2019
Q2 | $0 | Sell |
116
-61
| -34% | – | ﹤0.01% | 5551 |
|
|
2019
Q1 | $0 | Hold |
177
| – | – | ﹤0.01% | 5466 |
|
|
2018
Q4 | $0 | Hold |
177
| – | – | ﹤0.01% | 5462 |
|
|
2018
Q3 | $0 | Hold |
177
| – | – | ﹤0.01% | 5433 |
|
|
2018
Q2 | $0 | Hold |
177
| – | – | ﹤0.01% | 5200 |
|
|
2018
Q1 | $0 | Hold |
177
| – | – | ﹤0.01% | 5283 |
|
|
2017
Q4 | $0 | Hold |
177
| – | – | ﹤0.01% | 5195 |
|
|
2017
Q3 | $1K | Sell |
177
-40
| -18% | -$226 | ﹤0.01% | 4881 |
|
|
2017
Q2 | $2K | Hold |
217
| – | – | ﹤0.01% | 4662 |
|
|
2017
Q1 | $2K | Hold |
217
| – | – | ﹤0.01% | 4632 |
|
|
2016
Q4 | $2K | Buy |
+217
| New | +$2K | ﹤0.01% | 4587 |
|